Products of other enterprises
Description
- Effective against a wide range of pathogens. Class leading against penicillin resistant Streptococcus pneumoniae.
- Clinical efficacy of co-amoxiclav unchanged over 15 years
- Consistent efficacy in respiratory tract infections
- Unique mode of action - the β-lactamase inhibitor
- Effective against β-lactamase producing organismsespecially Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
- Activity against anaerobic bacteria - especially important in difficult-to-treat chronic otitis media and sinusitis
- Convenience of twice daily dosing
- Fleming drops for infants give more accurate dosing for infants below 30 months of age
- Fleming 300mg injection for infants reduces the cost of treatment
Contact the seller
Fleming Range